Target Price | $131.58 |
Price | $126.90 |
Potential |
3.69%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target IDACORP, Inc. 2026 .
The average IDACORP, Inc. target price is $131.58.
This is
3.69%
register free of charge
$147.00
15.84%
register free of charge
$121.20
4.49%
register free of charge
|
|
A rating was issued by 11 analysts: 7 Analysts recommend IDACORP, Inc. to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IDACORP, Inc. stock has an average upside potential 2026 of
3.69%
register free of charge
|
Dec '24 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 1.83 | 1.86 |
3.41% | ||
EBITDA Margin | 34.38% | 30.87% |
12.78% | ||
Net Margin | 15.83% | 15.91% |
7.06% |
Dec '24 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.50 | 5.47 |
7.00% | ||
P/E | 23.20 | |
EV/Sales | 5.41 |
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
UBS |
Locked
➜
Locked
|
Locked | Jun 02 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 22 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | May 02 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | May 02 2025 |
UBS |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Jul 11 2025 |
Locked
UBS:
Locked
➜
Locked
|
Jun 02 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 22 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
May 02 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
May 02 2025 |
Locked
UBS:
Locked
➜
Locked
|
Mar 21 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Mar 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.